CareerPlanSign in

Director, Oncology Bioanalytical Strategy Lead

US - Cambridge Kendall SQ - MA💼 Full-time💰 $175,498–$175,498🗓 2026-09-21 → 2026-09-26

Core

Lead the design and implementation of robust bioanalytical strategies (PK, immunogenicity, biomarkers) for oncology and immuno-oncology therapeutic modalities to support the AstraZeneca pipeline.

Role type

Director, Oncology Bioanalytical Strategy Lead

Builds

Bioanalytical assay designs, strategies, and data delivery for oncology portfolio programs

Domain

Biopharmaceuticals / Oncology / Bioanalysis

Deliverable

production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work

Required skills

Regulated bioanalysis strategy, complex biologics analysis, ADC/Radioconjugate/TCE expertise, immunogenicity assessment, global regulatory compliance, CRO management, assay transfer, data interpretation, line and matrix management, scientific publication

Preferred skills

Cell therapy experience, small molecule experience, deep flow cytometry expertise, operational process optimization

Technologies

Ligand binding assays, LC-MS, ddPCR, qPCR, RT-qPCR, flow cytometry, ELISpot, viral assays, cytokine assays

Responsibilities

Develop holistic bioanalytical strategies for oncology programs, serve as IBA project lead, collaborate with internal/external labs and CROs, manage stakeholder expectations, present at internal/external meetings, publish manuscripts, contribute to strategic initiatives, work with regulatory agencies

Seniority

Director, strategic leadership & mentorship

Sourced via workday · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.